Patricia T. Greipp

Dr. Patricia T. Greipp is a physician scientist at the Mayo Clinic within the Department of Laboratory Medicine and Pathology and Mayo Clinic College of Medicine. With a career spanning over two decades, she specializes in clinical cytogenetics and genomic sequencing for hematologic malignancies.

• Doctor of Osteopathic Medicine (1997), Philadelphia College of Osteopathic Medicine
• Postdoctoral Fellowship in B12-targeted imaging/therapy (2008), Mayo Clinic
• Residency and Fellowship in Hematology/Oncology (2005), Mayo Clinic

Her research focuses on multiple myeloma genomics, cancer cytogenetics, and molecular diagnostics for hematologic diseases. Recent publications highlight her contributions to therapeutic vulnerability screening and minimal residual disease (MRD) validation in myeloma.

Dr. Greipp's work intersects genetic mutations (e.g., BCOR, ETNK1) and clinical outcomes in myeloid neoplasms. She leads the Cytogenetics Core Facility at Mayo Clinic and contributes to Cancer Genomics Consortium initiatives.

• 2025: Third Place Poster Award (Cancer Genomics Consortium)
• 2013: Best Poster Award (Association of Genetic Technologists)
• 2007 & 2006: Michael A. O'Connor Award for Young Investigators

As a mentor and committee member, she guides hematopathology fellowship programs and participates in allogeneic transplant outcome analyses. Her leadership in CLIA-certified diagnostics ensures compliance with the College of American Pathologists.